IL1RN mediates the suppressive effect of methionine deprivation on glioma proliferation

Cancer Lett. 2019 Jul 10:454:146-157. doi: 10.1016/j.canlet.2019.04.004. Epub 2019 Apr 10.

Abstract

Metabolic abnormality is one of the hallmarks of cancer cells, and limiting material supply is a potential breakthrough approach for cancer treatment. Increasing researchers have been involved in the study of glioma cell metabolism reprogramming since the significance of IDH1 was confirmed in glioma. However, the molecular mechanisms underlying metabolic reprogramming induced by methionine deprivation regulates glioma cell proliferation remain unclear. Here we demonstrated that methionine deprivation inhibited glioma cell proliferation via downregulating interleukin 1 receptor antagonist (IL1RN) both in vitro and in vivo, methionine deprivation or knocking down IL1RN induced glioma cell cycle arrest. Moreover, we confirmed that IL1RN is a tumor associated gene and its expression is negatively correlated with the survival time of glioma patients. Altogether these results demonstrate a strong rationale insight that targeting amino acid metabolism such as methionine deprivation/IL1RN related gene therapy may offer novel direction for glioma treatment.

Keywords: Gene therapy; Glioma; IL1RN; Metabolic reprogramming; Tumor associated gene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Neoplasms / metabolism*
  • Brain Neoplasms / pathology
  • Cell Line, Tumor
  • Cell Proliferation / physiology
  • Down-Regulation
  • Glioma / metabolism*
  • Glioma / pathology
  • Heterografts
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / biosynthesis*
  • Interleukin 1 Receptor Antagonist Protein / genetics
  • Methionine / deficiency*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Transfection

Substances

  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • RNA, Messenger
  • Methionine